These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 2483430

  • 1. Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity.
    Waeber B, Nussberger J, Juillerat L, Brunner HR.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S53-9. PubMed ID: 2483430
    [Abstract] [Full Text] [Related]

  • 2. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
    Schalekamp MA, Derkx FH, van den Meiracker AH.
    J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650
    [Abstract] [Full Text] [Related]

  • 3. Plasma angiotensins under sustained converting enzyme inhibition with enalapril in normal humans.
    Nussberger J, Brunner DB, Waeber B, Brunner HR.
    J Hypertens Suppl; 1985 Dec; 3(3):S269-70. PubMed ID: 2856820
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
    Sadjadi J, Kramer GL, Yu CH, Welborn MB, Modrall JG.
    J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
    [Abstract] [Full Text] [Related]

  • 5. Renin vs. angiotensin-converting enzyme inhibition in the rat: consequences for plasma and renal tissue angiotensin.
    Allan DR, Hui KY, Coletti C, Hollenberg NK.
    J Pharmacol Exp Ther; 1997 Nov; 283(2):661-5. PubMed ID: 9353383
    [Abstract] [Full Text] [Related]

  • 6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 7. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects.
    Burnier M, Brunner HR.
    Exp Nephrol; 1996 Sep; 4 Suppl 1():41-6. PubMed ID: 9001896
    [Abstract] [Full Text] [Related]

  • 8. [Effect of a non-antihypertensive dose of ramipril on the plasma and tissue renin-angiotensin system in 27 TGR (mRen2) rats].
    Grima M, Anjuère J, Ingert C, Coquard C, Steger J, Barthelmebs M, Imbs JL.
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):805-12. PubMed ID: 11575208
    [Abstract] [Full Text] [Related]

  • 9. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ, Anastasopoulos F, Duncan AM, James GM, Kladis A, Briscoe TA.
    J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
    [Abstract] [Full Text] [Related]

  • 10. Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function.
    Neutel JM.
    J Hum Hypertens; 2004 Sep; 18(9):599-606. PubMed ID: 15190263
    [Abstract] [Full Text] [Related]

  • 11. [Do kinins have significance for the antihypertensive effect of angiotensin-converting enzyme inhibitors?].
    Bönner G.
    Z Kardiol; 1988 Sep; 77 Suppl 3():23-7. PubMed ID: 3062958
    [Abstract] [Full Text] [Related]

  • 12. Blockade of the renin-angiotensin system at different sites: effect on renin, angiotensin and aldosterone.
    Abdelrahman AM, Burrell LM, Johnston CI.
    J Hypertens Suppl; 1993 Apr; 11(3):S23-6. PubMed ID: 8315514
    [Abstract] [Full Text] [Related]

  • 13. Experience with perindopril in normal volunteers.
    Waeber B, Nussberger J, Perret L, Santoni JP, Brunner HR.
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():35-41. PubMed ID: 2549899
    [Abstract] [Full Text] [Related]

  • 14. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA.
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [Abstract] [Full Text] [Related]

  • 15. Antihypertensive effect of rice protein hydrolysate with in vitro angiotensin I-converting enzyme inhibitory activity in spontaneously hypertensive rats.
    Li GH, Qu MR, Wan JZ, You JM.
    Asia Pac J Clin Nutr; 2007 Mar; 16 Suppl 1():275-80. PubMed ID: 17392118
    [Abstract] [Full Text] [Related]

  • 16. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM, Plokker HW, Lok DJ, Boomsma F, van der Horst FA, van Veldhuisen DJ, van Gilst WH, Voors AA.
    Int J Cardiol; 2006 Jan 26; 106(3):367-72. PubMed ID: 16337046
    [Abstract] [Full Text] [Related]

  • 17. Kinin-related effects of angiotensin-converting enzyme inhibition.
    Bönner G.
    Clin Physiol Biochem; 1990 Jan 26; 8 Suppl 1():6-15. PubMed ID: 2257722
    [Abstract] [Full Text] [Related]

  • 18. Renal tissue angiotensins during converting enzyme inhibition in the spontaneously hypertensive rat.
    Grima M, Ingert C, Michel B, Barthelmebs M, Imbs JL.
    Clin Exp Hypertens; 1997 Jan 26; 19(5-6):671-85. PubMed ID: 9247747
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system.
    Brunner HR, Nussberger J, Waeber B.
    J Hypertens Suppl; 1993 Apr 26; 11(3):S53-8. PubMed ID: 8315521
    [Abstract] [Full Text] [Related]

  • 20. The physiological significance of the alternative pathways of angiotensin II production.
    Kramkowski K, Mogielnicki A, Buczko W.
    J Physiol Pharmacol; 2006 Dec 26; 57(4):529-39. PubMed ID: 17229979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.